Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Alzheon Inc. (Framingham, Mass.) proposed on Aug. 27 to raise up to $41.2
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury